EUVIMEDEUVIMED entdecken
Open Access

G2C4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neurons

Jeffrey D Rothstein, Victoria Baskerville, Sampath Rapuri, Emma Mehlhop, Paymaan Jafar-Nejad, Frank Rigo, Frank Bennett, Sarah Mizielinska, Adrian Isaacs, Alyssa N Coyne iD

Acta Neuropathologica · 2024

DOI: 10.1007/s00401-023-02652-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, 2024. Verfasst von Jeffrey D Rothstein und 9 weiteren Autor:innen. Beteiligte Einrichtung: Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. jrothstein@jhmi.edu. Hauptthemen laut MEDLINE: Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, Robert Packard Center for ALS Research, Johns Hopkins University, NIH NINDS/NIA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The G4C2 repeat expansion in the C9orf72 gene is the most common genetic cause of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Many studies suggest that dipeptide repeat proteins produced from this repeat are toxic, yet, the contribution of repeat RNA toxicity is under investigated and even less is known regarding the pathogenicity of antisense repeat RNA. Recently, two clinical trials targeting G4C2 (sense) repeat RNA via antisense oligonucleotide failed despite a robust decrease in sense-encoded dipeptide repeat proteins demonstrating target engagement. Here, in this brief report, we show that G2C4 antisense, but not G4C2 sense, repeat RNA is sufficient to induce TDP-43 dysfunction in induced pluripotent stem cell (iPSC) derived neurons (iPSNs). Unexpectedly, only G2C4, but not G4C2 sense strand targeting, ASOs mitigate deficits in TDP-43 function in authentic C9orf72 ALS/FTD patient iPSNs. Collectively, our data suggest that the G2C4 antisense repeat RNA may be an important therapeutic target and provide insights into a possible explanation for the recent G4C2 ASO clinical trial failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Frontotemporal DementiaAmyotrophic Lateral SclerosisInduced Pluripotent Stem CellsHumansOligonucleotides, AntisenseC9orf72 ProteinDNA-Binding ProteinsRNA, AntisenseDipeptidesNeurons

Stichwörter der Autor:innen

ALSAntisense oligonucleotidesC9orf72Induced pluripotent stem cell derived neuronsRepeat RNATDP-43

Substanzen

Oligonucleotides, AntisenseC9orf72 ProteinDNA-Binding ProteinsRNA, AntisenseDipeptidesC9orf72 protein, human

Autor:innen und Institutionen

  • Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. jrothstein@jhmi.edu.
  • Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. jrothstein@jhmi.edu.
  • Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
  • Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
  • Ionis Pharmaceuticals, Carlsbad, CA, 92010, USA.
  • UK Dementia Research Institute at King's College London, London, UK.

ORCID-Profile: Alyssa N Coyne

Förderung

  • NINDS NIH HHS
  • Robert Packard Center for ALS Research, Johns Hopkins University
  • NIH NINDS/NIA
  • Target ALS

Zitieren

APA

Rothstein, J. D., Baskerville, V., Rapuri, S., Mehlhop, E., Jafar-Nejad, P., Rigo, F., Bennett, F., Mizielinska, S., Isaacs, A., & Coyne, A. N. (2024). G2C4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neurons. Acta Neuropathologica. https://doi.org/10.1007/s00401-023-02652-3

Vancouver

Rothstein JD, Baskerville V, Rapuri S, Mehlhop E, Jafar-Nejad P, Rigo F, et al. G2C4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neurons. Acta Neuropathologica. 2024. doi:10.1007/s00401-023-02652-3

BibTeX
@article{Rothstein2024,
  author = {Rothstein, Jeffrey D and Baskerville, Victoria and Rapuri, Sampath and Mehlhop, Emma and Jafar-Nejad, Paymaan and Rigo, Frank and Bennett, Frank and Mizielinska, Sarah and Isaacs, Adrian and Coyne, Alyssa N},
  title = {G2C4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neurons},
  journal = {Acta Neuropathologica},
  year = {2024},
  doi = {10.1007/s00401-023-02652-3}
}
Kostenlos starten →